Activation of matrix metalloproteinase-2 by overexpression of manganese superoxide dismutase in human breast cancer MCF-7 cells involves reactive oxygen species

被引:165
作者
Zhang, HJ
Zhao, WL
Venkataraman, S
Robbins, MEC
Buettner, GR
Kregel, KC
Oberley, LW
机构
[1] Univ Iowa, Dept Radiat Oncol, Free Radical & Radiat Biol Program, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Exercise Sci, Iowa City, IA 52242 USA
关键词
D O I
10.1074/jbc.M109801200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Matrix metalloproteinases (MMPs) participate in cell migration and remodeling processes by affecting the extracellular matrix. MMP-2 is thought to be involved in cancer cell invasiveness. It has been proposed that the activity of MMP-2 can be modulated by intracellular reactive oxygen species (ROS)/reactive nitrogen species. We hypothesized that manganese superoxide dismutase (MnSOD) could mediate MMP-2 activity by changing the intracellular ROS level and that nitric oxide (NO) may be involved in this process. Human breast cancer MCF-7 cells were stably transfected with plasmids containing MnSOD cDNA. A 2-30-fold increase of MnSOD protein and activity was observed in four clones. Our data demonstrated that overexpression of MnSOD stimulated the activation of MMP-2 with a corresponding elevation of ROS. A decrease in ROS by ebselen, a glutathione peroxidase mimetic, or by transduction of adenovirus containing human catalase or glutathione peroxidase cDNA abolished the effect of MnSOD on MMP-2 activation. Treatment of MCF-7 cells with antimycin A or rotenone increased intracellular ROS production and MMP-2 activation simultaneously. Our data also showed a suppression of endothelial nitric-oxide synthase expression that was accompanied by decreased (NO)-N-. production in MnSOD-overexpressing cells. However, the changes in endothelial nitric-oxide synthase and (NO)-N-. did not correlate with the MnSOD activity. Corresponding changes of MMP-2 activity after the addition of a NOS inhibitor (N-G--amino-L-arginine) or a (NO)-N-. donor ((Z)-1-[(2-aminoethyl) -N-(2-ammonioethyl) amino]diazen-1-ium-1,2-diolate) to the cells suggested the possibility that (NO)-N-. may be involved in the MnSOD-mediated MMP2 activation pathway. These results indicate that MnSOD induces MMP-2 activity by regulation of intracellular ROS and imply that signaling pathways involving (NO)-N-. may also be involved in the MnSOD mediation of MMP-2 activity.
引用
收藏
页码:20919 / 20926
页数:8
相关论文
共 50 条
[1]   THE BALANCE BETWEEN CU,ZN-SUPEROXIDE DISMUTASE AND CATALASE AFFECTS THE SENSITIVITY OF MOUSE EPIDERMAL-CELLS TO OXIDATIVE STRESS [J].
AMSTAD, P ;
PESKIN, A ;
SHAH, G ;
MIRAULT, ME ;
MORET, R ;
ZBINDEN, I ;
CERUTTI, P .
BIOCHEMISTRY, 1991, 30 (38) :9305-9313
[2]  
AMSTAD P, 1994, J BIOL CHEM, V269, P1606
[3]  
BASS DA, 1983, J IMMUNOL, V130, P1910
[4]   SUPEROXIDE DISMUTASE - IMPROVED ASSAYS AND AN ASSAY APPLICABLE TO ACRYLAMIDE GELS [J].
BEAUCHAM.C ;
FRIDOVIC.I .
ANALYTICAL BIOCHEMISTRY, 1971, 44 (01) :276-&
[5]   APPARENT HYDROXYL RADICAL PRODUCTION BY PEROXYNITRITE - IMPLICATIONS FOR ENDOTHELIAL INJURY FROM NITRIC-OXIDE AND SUPEROXIDE [J].
BECKMAN, JS ;
BECKMAN, TW ;
CHEN, J ;
MARSHALL, PA ;
FREEMAN, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (04) :1620-1624
[6]   MATRIX METALLOPROTEINASES - A REVIEW [J].
BIRKEDALHANSEN, H ;
MOORE, WGI ;
BODDEN, MK ;
WINDSOR, LJ ;
BIRKEDALHANSEN, B ;
DECARLO, A ;
ENGLER, JA .
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 1993, 4 (02) :197-250
[7]  
Bostwick DG, 2000, CANCER, V89, P123, DOI 10.1002/1097-0142(20000701)89:1<123::AID-CNCR17>3.0.CO
[8]  
2-9
[9]   SOD2 - A NEW TYPE OF TUMOR-SUPPRESSOR GENE [J].
BRAVARD, A ;
SABATIER, L ;
HOFFSCHIR, F ;
RICOUL, M ;
LUCCIONI, C ;
DUTRILLAUX, B .
INTERNATIONAL JOURNAL OF CANCER, 1992, 51 (03) :476-480
[10]   Hydrogen peroxide (H2O2) increases the steady-state mRNA levels of collagenase/MMP-1 in human dermal fibroblasts [J].
Brenneisen, P ;
Briviba, K ;
Wlaschek, M ;
Wenk, J ;
ScharffetterKochanek, K .
FREE RADICAL BIOLOGY AND MEDICINE, 1997, 22 (03) :515-524